Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study

A. Yeo (Stevenage, United Kingdom)

Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Session: Asthma genetics and genomics in patients and populations
Session type: Poster Discussion
Number: 1824
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Yeo (Stevenage, United Kingdom). Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study. 1824

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing
Source: ERJ Open Res, 4 (1) 00108-2017; 10.1183/23120541.00108-2017
Year: 2018



A pilot study to establish if the use of target saturation wristbands for community respiratory patients improves patient safety.
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020


Wireless mobile tehcnologies facilitates home-based data collection and processing in large epidemiological surveys: results from the IMCA-HES feasibility study
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

Establishment of an integrated clinical network and comprehensive data warehouse for the conduct of comparative effectiveness research in COPD
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011


From research question to dissemination: how to design, analyse and present study results
Source: Breathe, 14 (3) 232; 10.1183/20734735.020018
Year: 2018



ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies
Source: Virtual Congress 2020 – New developments in pandemic medicine
Year: 2020


Challenges in classification of asthma severity from prescription data: a pilot study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design
Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020
Year: 2020



Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies
Source: Guideline 1997
Year: 1997

Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Novel study design to assess the utility of the COPD assessment test (CAT)
Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care
Year: 2011

A technical and functional assessment of office spirometry devices. A multicentre comparative study
Source: Eur Respir J 2004; 24: Suppl. 48, 87s
Year: 2004

A pilot study to test the feasibility of histological characterisation of asthma–COPD overlap
Source: Eur Respir J, 53 (6) 1801941; 10.1183/13993003.01941-2018
Year: 2019



Some principles and practices of genetic biobanking studies
Source: Eur Respir J 2009; 33: 419-425
Year: 2009



New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



Comparative study concerning the assessment methods for asthma control
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Evaluation of a method for establishing biologic quality control ranges from the first 20 acceptable test sessions in a large multi-center study
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017